Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Consortium of Multiple Sclerosis Centers (CMSC) 2022 Annual Meeting
June 01 - 04, 2022; National Harbor, Maryland
June 01 - 04, 2022National Harbor, Maryland
CMSC 2022Novel Drug Safe, Effective in Relapsing MS: 2-Year DataThe investigational evobrutinib, an Bruton's tyrosine kinase inhibitor, showed favorable safety and efficacy in the longest trial to date of a drug in this class in patients with multiple sclerosis.
Medscape Medical News, June 9, 2022
CMSC 2022Non-White MS Patients Rarely Included in TrialsOver 25 years of clinical research, phase 3 trials of approved disease-modifying therapies for multiple sclerosis were overwhelmingly made up of White participants, new research shows.
Two Diets Linked to Improved Cognition, Fatigue in MSPaleolithic elimination and low-saturated fat diets are associated with improvements in fatigue, cognitive dysfunction, and
quality of life in patients with multiple sclerosis, new research suggests.
Medscape Medical News, Oct 28, 2021
DMTs Often Switched During COVID, but Was It Necessary?Many US clinicians who treat for multiple sclerosis adjusted drug regimens during the pandemic's early months to lower risk
for COVID-19 infection -- but they didn't need to, experts say.
